Investigation of Efficacy and Safety of EPOGAM

• Status: Completed
• Trial end date: 2010-10-01

Summary

In this study it will be investigated if patients with atopic dermatitis responding to EPOGAM treatment, show a significant increase of dihomo-gamma-linolic acid in the blood.

• Phase: Phase 4

Details

• Lead Sponsor: Max Zeller Soehne AG
• Treatments: Efamol; Evening primrose oil